← All organizations

Tanox

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Feb 1, 2008

Acquired by Genentech → Roche on Jan 1, 2007

Timeline

1980s

Jan 1, 1986
Tanox— Founded

2000s

Jan 1, 2007
Genentech— Acquired By
Jan 1, 2009
Roche— Now

Drugs by trial phase (4 distinct, 7 trials)

Phase 4 (1 own, 0 via acquisition)

omalizumab

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

tnx-832

Indications

Studied for

Recent trials (7)

NCT00624832CollaboratorPhase 4Feb 1, 2008
NCT00500539CollaboratorPhase 3Jul 1, 2007
NCT00441818Lead sponsorPhase 1/Phase 2May 1, 2006
NCT00267202CollaboratorPhase 4Dec 1, 2005
NCT00264849CollaboratorPhase 4Nov 1, 2005
NCT01438853CollaboratorPhase 1Dec 1, 2004
NCT00089700Lead sponsorPhase 2Mar 1, 2004

Details

Founded: Houston, TX, US Jan 1, 1986
Last known activity: Feb 1, 2008